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Epigenetics is the study of changes in gene expression caused by mechanisms
other than changes in the DNA itself. The ﬁeld is rapidly growing and being
widely promoted, attracting attention in diverse arenas. These include those
of the social sciences, where some researchers have been encouraged by the
resonance between imaginaries of development within epigenetics and social
theory. Yet, sustained attention from science and technology studies (STS)
scholars to epigenetics and the praxis it propels has been lacking. In this
article, we reﬂexively consider some of the ways in which epigenetics is
being constructed as an area of biomedical novelty and discuss the content
and logics underlying the ambivalent promises being made by scientists
working in this area. We then reﬂect on the scope, limits and future of
engagements between epigenetics and the social sciences. Our discussion is
situated within wider literatures on biomedicine and society, the politics of
“interventionist STS”, and on the problems of “caseness” within empirical
social science.
Keywords: epigenetics; promise; novelty; social science; cancer; methylation
Introduction
As “omics” science proliferates and the complexity of biological systems becomes
the overarching ontology in the life sciences, epigenetics has come to play an
increasingly central role in today’s molecular landscape. Grants, infrastructure,
patents, journals, and awards all form increasingly visible constituents of this
ﬁeld, helping to construct it as novel and important. Often regarded as a branch
of genetics, epigenetics articulates with developmental biology, endocrinology,
immunology, plant science, psychiatry, and other interdisciplinary domains. In epi-
genetics, changes perceived as salient when compared with more “traditional”
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genetic approaches include an investigative focus on “what genes can’t do” (Moss
2003). In particular, research and theorization in epigenetics presents challenges to
and enrichments of dominant strands of evolutionary theory and the widely instan-
tiated (though not hegemonic) “gene-centric” model of life (Barnes and Dupre´
2008; Jablonka and Lamb 2006). Epigenetics is claimed to be “one of the most
promising and expanding ﬁelds in the current biomedical research landscape”
(Rodrı´guez-Paredes and Esteller 2011, 330).
Research in epigenetics today is primarily concerned with the investigation of
changes in gene expression, where the mechanism for this is something other
than a change to the underlying DNA. The focus of research is on the dynamics
of chemical modiﬁcation upon the DNA, which enhance, decrease, initiate or
silence gene expression. One of the key processes is methylation, the addition of
a chemical compound called a methyl group to a DNA base. Biologists understand
epigenetic regulation of gene expression as essential to organismal development,
playing important roles in diverse processes such as cell differentiation and
genomic imprinting (Feil and Fragga 2012). Epigenetic changes may be mitotically
(or even meiotically) heritable – although how far this is or could be the case is still
debated. Whilst, a decade or so ago, investigators emphasized the heritable aspect
of epigenetic changes, more “recent deﬁnitions are less stringent” (Bohacek and
Mansuy 2013, 221).1
In spite of the expanding discourse of epigenetics, the term itself was ﬁrst intro-
duced over 70 years ago, within the realm of embryology: epigenetics is not, in
many senses, “new”, and the ways in which is it constructed as novel speak to
wider debates about the scope and nature of biomedicine. Biomedical researchers
(and others, such as plant scientists) have come to invest both symbolic and material
capital in epigenetics. As with some contemporary research in neuroscience (Pick-
ersgill 2009), epigenetics represents “a concept, a horizon of research, and an assem-
blage of ideas and practices [that] brings the environment back into the postgenomic
era” (Rapp 2011, 669). Accordingly, wet and dry laboratory ﬁndings exhibit a
certain amount of “interpretative ﬂexibility” (Pinch and Bijker 1984) that lend them-
selves well to inclusion in the ontological projects of a range of actors. These include
practitioners of spiritual healing and environmental activists interested in the
relationships between minds, bodies and societies, as well as social scientists.
Whilst sustained attention to epigenetics from anthropologists, sociologists, STS
scholars and bioethicists has been lacking, “corridor talk” – that “key means of intel-
lectual (re)production” (Downey, Dumit, and Traweek 1998, 245) in the social
sciences – has begun to embed promises and expectations about this ﬁeld.2
Our aim in this article is to sketch out some of the biomedical, social scientiﬁc,
bioethical and public dialogue around epigenetics, in order to locate the various
considerations and concerns that are being ﬁgured as salient in regards to this
ﬁeld. Our position derives from a range of documentary analysis, participant obser-
vation and observant participation at various meetings and events pertaining to epi-
genetics, and a laboratory ethnography (conducted by Niewo¨hner). Throughout,
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the article is grounded by our sense that ﬁrst, as an area of increasing interest within
biology and medicine some examination of epigenetics by STS scholars seems war-
ranted; and second, epigenetics proves a useful case for exploring some of the
debates currently being played out across different realms of STS in regards to
the diverse roles played by social scientists within technoscientiﬁc innovation.
Towards biomedical novelty
The term “epigenetics” was ﬁrst coined by embryologist Conrad Waddington in his
1940 book, Organisers and Genes; famously, this involved the metaphor of the
“epigenetic landscape” to characterize the different ways in which environmental
circumstances could inﬂuence gene expression and consequently modulate devel-
opment. Early twentieth-century epigenetic theory “conceived the organism as a
product of the reaction between a particular kind of protoplasm, whether in the
form of a single cell or of many cells, and environmental factors” (Sapp 1987,
7). Since then, the term “epigenetics” has come to be rather mobile, articulated
though a range of biomedical ﬁelds and approaches. Today, research in this vein
is most broadly concerned with what “genes alone do not explain” (Lock 2011,
694).
Waddington is a frequent reference point in review articles and editorials on epi-
genetics, serving as a means of “colonising the past” (Morrison 2012, 3) that estab-
lishes the legitimacy of the ﬁeld and is suggestive of conceptual and empirical
advancement in ways that invite anticipation of developments not yet made. The
act of pointing to a lineage implies that “the” origin of epigenetic research is unfa-
miliar to many scientists; hence it must be a little quirky, a little beyond the main-
stream of biomedicine. Yet, simultaneously, through being detailed in high-proﬁle
journals such as Nature and Science, its legitimacy is nevertheless assured. Refer-
ences to and discussion of Waddington and other long-dead scientists are thus, in
this context, central to establishing epigenetics as a form of biomedical novelty
(and thus worthy of attention, and perhaps investment), but nonetheless one with
a rich genealogy.
The notion that epigenetics is a novel scientiﬁc enterprise is further substantiated
by (as well as acting as a driver for) the range of initiatives that are currently pro-
viding research infrastructure for epigenetic endeavors.3 Such initiatives aim to
foster international collaboration, integrate early-career researchers into wider pro-
fessional networks, facilitate translational research, and coordinate the production
of reference maps of epigenomes. These multilateral enterprises are diversely
developed through scientists’ own “grassroots” (Satterlee, Schu¨beler, and Ng
2010, 1041) epistemic activism as well as through “top down” initiatives designed
to stimulate innovation through mandating collaboration (cf. Defazio, Lockett, and
Wright 2009). In general, these platforms (Keating and Cambrosio 2000) are devel-
oped reﬂexively, and their development often produces strategic responses that are
of importance to those trying to understand the dynamics of the epigenetics ﬁeld.4
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Such responses are particularly evident in regards to the US American National
Institutes of Health (NIH) Roadmap Epigenomics Program, which sparked con-
siderable resistance from within biology. Here, the dynamic and tissue- and cell-
speciﬁc nature of epigenetic markings was regarded as escaping the static
mapping methodologies favored by those building this biomedical platform (cf.
Madhani et al. 2008). While many scientists seem to agree that the dynamism
and speciﬁcity of epigenetic changes pose some new and very different challenges
to methodology, the existence of established high throughput tools and frameworks
for processing large amounts of individual ﬁndings across research groups presents
the stronger argument in discussions about the direction of funding streams. This
instance of platform-building demonstrates very clearly how the ﬁeld is driven
by technology, method and “do-ability” (Fujimura 1987), as well as by the
nature of the biological problems at hand. In the process, the scientiﬁc problem
itself can be reframed, with implications for the identities of the platform, and
the knowledge being produced as “novel”.
In situating epigenetics as a form of biomedical novelty, claims-makers must over-
come the regularly expressed doubts of their colleagues who argue that it is simply a
variant of established research on gene expression (Niewo¨hner 2011). One way of
doing this is through the circulation (in review articles, monographs, popular
media and so on) of particularly striking epigenetic investigations that have produced
ﬁndings that are compelling to scientists and wider publics. Key examples are the
experimental animal studies of the research groups around Michael Meaney and
Moshe Szyf on the impact of maternal behavior on methylation patterns, as well
as epidemiological studies on the effects of the “Dutch Hunger Winter”. Meaney,
Szyf and colleagues in Montreal started their experimental work on northern
hooded rats from the well-observed “maternal” behavioral features of “arched-
back nursing” and “licking and grooming” (Weaver et al. 2004). In the wild, rats
display these behaviors in a broad spectrum of intensity such that groups of more
or less intense arching and licking can be identiﬁed in any given population. The
initial experimental set-up focused on the effects of these two types of nursing behav-
ior on the methylation status of a stress-relevant receptor in the rats’ hippocampus.
Offspring that were nursed by “low” nursing mothers displayed signiﬁcantly
increased methylation at the receptor site compared to “high” nursing mothers. To
biologists, this effect confers a higher susceptibility to stress on the affected
animal. The effect emerges in the ﬁrst week of the offspring’s lives, can be reversed
through cross-fostering and drug treatment, and persists into adulthood. Further
experiments since have shown that effects of this type can be semi-stable across gen-
erations and in principle may also exist in humans (e.g. McGowan et al. 2009).
Yet, while effects on the germline have been reported for psychiatric phenomena
in mammals (Franklin et al. 2010, 2011), so far no effects have been shown to be
truly stable and persistent into non-exposed generations (Daxinger and Whitelaw
2012). This is understood by many epigenetics researchers to imply the existence
of some kind of resetting mechanism, operating in a manner that is beyond current
432 M. Pickersgill et al.
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bioscientiﬁc comprehension. The most recent research particularly in plants points
to an increasingly complex regulatory network involving not only DNA and epige-
netic markers but also a whole range of microRNAs in- and outside the cell nucleus
(e.g. Aregger et al. 2012; Molnar et al. 2010). Researchers now speak of “meta-
stable epialleles” (e.g. Rakyan et al., 2002) to refer to the fact that variation
occurs above the level of DNA, is stable through somatic inheritance, and has
non-deterministic effects on phenotype. Such non-stochastic variations in epige-
netic status can be induced by an organism’s socio-material environment. Thus,
what emerges here is a molecular science of environmental impacts on mammalian
development and reproduction.
Neither the ﬁndings on the effects of the environment on biology and health, nor
their transmissibility, are new in principle. As Lock (2013) has likewise noted,
several statistical analyses in epidemiology have shown similar phenomena.
Most prominently perhaps, researchers have shown that the extreme malnutrition
of Dutch pregnant women during a clearly deﬁned hunger period in the war
Winter of 1944–45 has had an effect on these womens’ grandchildren, increasing
their cardiovascular risk (Roseboom, de Rooij, and Painter 2006). The Whitehall II
study conducted on civil servants in England to measure the effect of social position
on health also clearly showed effects of the social environment on health (Brunner
1997). What Meaney and Szyf are regarded to have added with their proof of prin-
ciple experimental studies is a clearly deﬁned molecular mechanism for the socio-
material environment to have a lasting effect on the human body. Further, their
studies have reinvigorated longstanding questions around the transmission and her-
itability of acquired features.
Today, we can comprehend “new uses of the older concept of epigenetics and
a willingness to let the post-genomic world of environmental complexity into
the research picture” (Rapp 2011, 678). Debates are playing out within biology as
to whether we are seeing “the demise of the gene” (Newman 2013), and hence a
(potential) deceleration of research that is underpinned by a gene-centric view of
life – though of course such as conception of life was never uniformly accepted
in biomedicine anyway (Barnes and Dupre´ 2008). Yet, technologies of genomics
nevertheless helped to (re)produce an understanding of genes as a foundation
stone of development, with the fuzziness of “the environment” a secondary consider-
ation. As epigenetics research continues, more interactive and dynamic models are
being operationalized within laboratories (Beck and Niewo¨hner 2006); these intro-
duce new and challenging puzzles for scientists to solve – including what, if any,
health beneﬁts for populations could be afforded through epigenetic knowledge
production.
Producing promise?
To a limited degree, epigenetic ideas – especially those emerging from or relating
to the studies described in the previous section – are also translating into popular
New Genetics and Society 433
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culture, with magazines and popular science books discussing the consequences of
research and fuelling further speculation. As one writer of popular science remarks
in the provocatively titled The Epigenetics Revolution, “we are ﬁnally starting to
unravel the missing link between nature and nurture; how our environment talks
to us and alters us, sometimes forever” (Carey 2012, 7). Often, the ﬁndings enrolled
in online and print media are results from animal studies, raising questions about
what part epigenetics is playing in the mediation of public understandings regard-
ing the relationships between animal and human minds, bodies and (social)
environments. More broadly, the instantiation of epigenetic concepts within
public discourses provides new resources through which people can “make up”
(Hacking 2002) themselves and one another (cf. Bro¨er and Heerings 2013; Pickers-
gill, Cunningham-Burley, and Martin 2011).5
Yet, the implications of research in epigenetics for science, health and society are
unclear. Scientiﬁc commentaries and review articles are threaded through with dis-
cussions of uncertainties and unknowns: tentative “coulds” and hopeful “mays”
commonly steer these narratives.6 For instance, the contributions of extrinsic
environmental factors on stochastic epigenetic changes are “largely unknown”
(Feil and Fragga 2012, 97), the effects of methylation on morphological transitions
in insects is “unclear” (Feil and Fragga 2012, 98), and whether temperature-depen-
dent sex determination in a range of animals has anything to do with methylation
“remains to be explored” (Feil and Fragga 2012, 98).7 Identifying uncertainties as a
means of signposting further research that might bear fruit is of course a key func-
tion of review articles, and in so doing a means of marshaling symbolic and
material resources for particular epistemic agendas (Arribas-Ayllon et al. 2010).
Nevertheless, it could also be useful to consider whether the embracing of complex-
ity and candid discussions of uncertainty in epigenetics has other origins. In par-
ticular, we might speculate that it could reﬂect a wider tendency within the
biological sciences today to move away from the bold assertions of clinical rel-
evance and ontological clariﬁcation that have been argued to characterize the dis-
courses of scientists in previous decades (e.g. Borup et al. 2006; Hedgecoe and
Martin 2008; and references therein).8
This is not, however, to say that promissory discourse is invisible within major
biomedical fora such as the journals Nature and Cell. As the abstract of one review
paper in Nature Biotechnology asserts: “Epigenetics is one of the most rapidly
expanding ﬁelds of biology”, scientiﬁc interest in which “has been accompanied
by technological breakthroughs”, and “a comprehensive understanding of epige-
netic mechanisms, their interactions and alterations in health and disease, has
become a priority in biomedical research” (Portela and Esteller 2010, 1057).
The corresponding author of this review – Manel Esteller of the Bellvitge Institute
for Biomedical Research, and a holder of various patents around cancer epige-
netics – has likewise noted in another review article for Nature Medicine that:
“We have already entered the epigenetics era” (Rodrı´guez-Paredes and Esteller
2011, 336).
434 M. Pickersgill et al.
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Cancer especially has been a key locus of research in epigenetics; as was noted in
a “Special Section” on cancer genomics in the journal Science, investigations are
“increasingly focused on the determinants of heterogeneous epigenetic states in
tumours” (Suva`, Riggi, and Bernstein 2013, 1570). Studies showing that tumor
cells may exhibit altered patterns of DNA methylation have motivated a range of
investigations (Das and Singal 2004; Laird and Jaenisch 1996), and the promissory
aspect of epigenetics is perhaps most readily discernible in the realm of oncology.
Already, various patents around cancer epigenetics have been administered; further,
“epigenetic drugs” are now on the market, such as Zolinza, a histone deacetylase
inhibitor manufactured by Patheon for Merck. Collectively, these therapeutics
had global annual sales of over $1 billion by 2011 (Visiongain 2011). According
to a 2013 “Biobusiness Brief” in Nature Reviews Drug Discovery, “recent progress
in showing that enzymes involved in epigenetic processes can be modulated by
drug-like small molecules, has fuelled interest in exploiting the therapeutic poten-
tial of epigenetic targets” (Burridge 2013, 92); some companies are speciﬁcally
focusing on epigenetic drugs, and GlaxoSmithKline houses a Cancer Epigenetics
Discovery Performance Unit operating out of Pennsylvania.
In spite of the interests of the pharmaceutical industry, however, potential treat-
ments for conditions associated with epigenetic mechanisms such as methylation
need not necessarily relate to drug treatments and wider processes of pharmaceu-
ticalization (Abraham 2010; Williams, Marin, and Gabe 2011). Rather, the
authors of one recent psychiatric study, for instance, assert that their results
“support the idea” that particular “epigenetic marks may be changed through psy-
chotherapeutic approaches and that these changes underline changes in cognitive
functions” (Perroud et al. 2013, 1). Accordingly, existing psychological and
environmental interventions may come to ﬁnd new legitimacy through research
in epigenetics (as has been the case in the neurosciences). The sociotechnical
assemblages constitutive of the epigenetics ﬁeld therefore resist easy characteriz-
ation, and so demand empirical and theoretical attention from social scientists.
Epigenetics and society
Many scientists working in (epi)genetics accept that “genes do not have clearly
demarcated beginnings or ends; nor are they stable, and only very rarely indeed
do they determine either individuals” phenotypes or the biological make-up of
future generations” (Lock and Nguyen 2010, 336). Such refusal to grant ontologi-
cal primacy to DNA is attractive to anthropologists and sociologists who have long
been critical of various forms of genetic determinism. Epigenetics represents a fron-
tier that it is perhaps especially exciting to explore to those social scientists who
remain frustrated by an apparent dearth of attention to the “organic, bodily and
environmental aspects and dimensions of human social life” (Benton 1991, 25),
as well as to sociologists of the body and of embodiment (Williams, Birke, and
New Genetics and Society 435
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Bendelow 2003). We will discuss this further in the next section; ﬁrst, though, we
must consider what kind of “environment” epigenetics is constructing.
Epigenetic research into health and illness is often concerned with the ways in
which “the environment” leaves its mark on the genome, and how this then pro-
duces particular phenotypic effects. What actually counts as “the environment”
is a complicated question, operationalized in diverse ways across experiments
and different spatial scales; as Landecker (2011) shows, even “food is now also
a conditioning environment that shapes the activity of the genome and the physi-
ology of the body” (167). Through these wide-ranging but often highly speciﬁed
constructions of the environment, epigenetics contributes to a “molecularization
of biography and milieu” (Niewo¨hner 2011, 279) that more ﬁrmly situates the
study of embodied subjects within the purview of laboratory science. The idea of
“early life adversity” and its presumed effects is important in structuring some of
the experimental approaches to epigenetics. This aligns neatly with contemporary
health and social policy discourses, with their emphases on early development,
environment and intervention and the biologically malleable human body this
entails.
Yet, the social and ethical implications of epigenetics (and especially conceptu-
alizations of “the environment”) have, to-date, received limited attention – though
the beginnings of a bioethical discourse are apparent. Barnes and Dupre´ (2008)
have argued that “the extent of the stability of methylation could turn out to
have great ethical signiﬁcance” (93); likewise, Rothstein, Cai, and Marchant
(2009) – writing on the ethics of epigenetics in Nature Reviews Genetics –
regard possible issues pertaining to environmental justice, intergenerational
effects, access to health care, and privacy and conﬁdentiality matters as important.
In so doing, they co-mingle established and more contemporary ethical concerns,
re-embedding late twentieth-century and more recent discussions about “genethics”
into a new discourse on the implications of epigenetics (which they seek to shape).
Cognizant of some of the mutations in developmental imaginaries potentially being
powered by research in epigenetics, political scientist Hedlund (2012) has noted the
shifts in responsibilization that could be affected. Debates about the ethical dimen-
sions of epigenetics may prove to be around the responsibilities of states to citizens;
this is in contrast to the bioethical commentaries on and analysis of free will and
individual responsibility that have been stimulated by other recent work in
biomedicine.
Noteworthy in this context is the development, and societal implications, of
environmental epigenetics; this can be seen as in part enabled and propelled
through a broader molecularization of toxicology (Shostak 2005). As Mansﬁeld
(2012) notes, public health and social care advisories from governments or other
institutions that draw from such research potentially extend state surveillance
and the disciplining of particular groups of actors. In regards to the potential (epi-
genetically determined) health consequences of eating certain foods that may
contain contaminants, for example, women come to be enjoined to “worry about
436 M. Pickersgill et al.
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the effects of chemicals on future foetuses” (Mansﬁeld 2012, 359, emphasis in orig-
inal; see also Landecker 2011). In effect, women are framed through some kinds of
epigenetics research as the ﬁrst environment for children, potentially activating and
augmenting a range of moral discourses and subjecting them to (increased) scrutiny
(Mu¨ller and Kenney, in preparation; Singh 2012).9
Relatedly, reports on the aforementioned experiments with rats (which found that
pups which have been licked less by their mothers become more aggressive and
anxious) evoke stereotypical images for female responsibility for their offspring’s
fate. As in other (bio)medical ﬁelds, it became obvious that also in epigenetics bio-
medical knowledge and the social structures of parenting, gender and family life
mix in a range of ways, sometimes unexpectedly and often in the process creating
new ways to be anxious, concerned, and expectant (Browner and Preloran 2010).
Accordingly, in spite of Hedlund’s normative suggestion urging that any ethical fra-
mework for epigenetics should be concerned with the duties of states, we may
nevertheless ﬁnd that biomedical research in this area will create further ways in
which individuals can be responsibilized: in particular, as care-takers of life that
does not yet exist.
Recent scholarship on personalized medicine and the racialization of pharmaceu-
ticals (Kahn 2013) also suggests that we must be attentive to the possibility that
epigenetic drugs may become targeted to particular populations, reinforcing cul-
tural assumptions about “race” and underscoring the somatic rather than societal
aspects of health and illness. On the other hand, however, the arguably stale
debates about the “biological” and “social” causes of increased cardiovascular
disease in “Black Americans” has moved forward in potentially productive ways
through epigenetics; this is used as a means to deconstruct simple biological
notions of race and foreground the necessary entanglement of nature and nurture
in processes of socio-material change (Kuzawa and Sweet 2009). This further
underscores the complexity of delineating and deﬁning social scientiﬁc “targets”
of critique and intervention.
While determinist readings of epigenetics ﬁndings are highly problematic and
widely contested, it is also worth noting that some of these resonate with received
wisdom both in the social and biological sciences. From an STS perspective
informed by the sociology of scientiﬁc knowledge (SSK), we might read this as
being part and parcel of the processes through which epigenetics research comes
to be legitimated and authorized. However, other social scientists might note
how some ideas current within epigenetics – such as imprinting – have received
strong backing from a range of quarters including epidemiology, psychoanalysis
and even certain social theories. Bourdieu’s notion of the habitus, for instance, is
suggestive of a view that understands people as “predisposed” to certain milieu
and not others. This, we believe, has a variety of implications, emerging from differ-
ent conceptual bases: for the novelty ascribed to epigenetics, for its cultural traction,
for its potential import for health and society, and hence for the kinds of contestation,
critique and collaboration that might be expected from social scientists.
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Engaging epigenetics and social science
As noted above, some scholars have been encouraged by the resonance between
imaginaries of development within epigenetics and sociological theory. Further,
epigenetics researchers have argued for the necessity for mutual engagements
between biomedical and social scientists; as McGowan and Szyf (2010) concluded
in the ﬁnal two sentences of a recent review article:
[U]nderstanding the epigenetics consequences of social exposures stands not only to
revolutionize medicine but also to transform social sciences and humanities as well.
Epigenetics could serve as a bridge between the social sciences and the biological
sciences, allowing a truly integrated understanding of human health and behaviour.
(71)
Yet, as Lock and Nguyen (2010) note, within the ﬁeld of epigenetics “networks
involving social scientists, social epidemiologists, and basic scientists – for-
mations that might well incite radical change and insights – remain very rare
indeed” (338). Such networks may be difﬁcult to establish, not least because
of the importance of (co-)developing infrastructure to undergird interdisciplinary
work. This will involve, for instance, constructing the material and social scaf-
folding needed to support research which produces and uses both biological and
sociological data.10
Attempts, however, are being made to produce hybrid communities that can
undertake epigenetics research that is responsive to social scientiﬁc insights and
ﬁndings: the UK Economic and Social Research Council (ESRC), for instance,
held an “International Challenge Symposium” in Edinburgh in June 2012 on
“Social Science and Epigenetics: Opportunities and Challenges” (ESRC 2012).
This brought into conversation life, medical, psychological and social scientists
to discuss the beneﬁts epigenetics might afford the academy in terms of new under-
standings of the lived body, actively promoting interdisciplinary approaches.
Initiatives such as this – reminiscent of those seen in synthetic biology (Moly-
neux-Hodgson and Meyer 2009) – seek to enroll investigators into a particular
research agenda, and are structured by logics of innovation and ontology (Barry,
Born, and Weszkalnys 2008): they seek to both propel sociotechnical change
and (co-)produce novel conceptualizations of biosocial entities.
There are challenges such endeavors, however. For their part, biologists may be
hesitant to incorporate the complexity of social life and sociological data within
their studies, given that the biological systems themselves are not yet well charac-
terized. Moreover, given the current trend towards fast-paced, publication-focused
knowledge production in the life sciences, collaboration even within these disci-
plines is not straightforward (Mu¨ller 2012). Social scientists, on the other hand,
may also be reticent to playing the role of what many might see as “handmaiden”
to life scientists, conforming to an investigative enterprise that they understand as
being developed from outside the space of their own intellectual regimes. Further,
many working in STS, sociology, anthropology and other disciplines will be
438 M. Pickersgill et al.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 E
din
bu
rg
h]
 at
 02
:32
 27
 M
arc
h 2
01
4 
sensitive to the social assumptions and implications (as discussed above) that are
embedded within and emerge from epigenetics.
Assuming the concerns of social scientists and humanities scholars around the
production, circulation and (potential) reception of epigenetic knowledge are
reasonable, however, is in fact itself a good reason to engage in collaborative enter-
prises with life scientists. Partnerships and mutual engagements between tech-
noscience and social science are increasingly common –part of and mobilized
by a wider “interventionist turn in science and technology studies” (Allhutter
2012, 684) – with a range of alliances between STS practitioners in the ﬁelds of
IT, nanotechnology and synthetic biology currently underway. Collaboration
between epigenetics and social science might likewise afford beneﬁt to the disci-
plines involved. How such collaboration might progress remains an open question,
though both empirical and conceptual approaches from the social sciences might be
useful in epigenetic studies, and epigenetic biomarkers might be instructive to
include in social scientiﬁc health research (Timmermans and Haas 2008). In parti-
cipating in such interdisciplinary research, we might consider the wide-ranging
engagements social scientists have had with genetics (e.g. Freese and Shostak
2009), including through the sharpening of explanatory models of biosocial inter-
actions, their somatic effects, and societal consequences (see also Von Scheve
2011). While overly simpliﬁed deterministic readings of epigenetics are, we feel,
to be avoided, some social scientists may willingly embrace the intellectual chal-
lenge of innovative concepts that are able to deal with the situated entanglement
of material and social elements within processes of human development. Engaging
critically in, for example, processes of translation – particularly with regards to
social, welfare and health policy – might also provide a niche for a social scientiﬁc
contribution that may be seen as essential by public and private funders.
As an authorial collective, we each have different viewpoints on these matters,
with our own normative assumptions, stakes and aspirations. Accordingly, we do
not advocate a way for social scientists to treat or work with epigenetics; rather,
we consider that a range of approaches – social science “in” or “of” epigenetics
(pace Straus 1957) – are most likely to bare intellectual fruit. We are somewhat
reluctant to follow the rather breathless calls to reinvigorate social science
through collaboration with life scientists that can be heard in certain quarters –
not least because what, exactly, it is about the social sciences that is so lacking
in vigor is seldom explicated. Further, we remain reﬂexively aware of the
diverse ways in which biomedical promises can shape social scientiﬁc research
agendas (Hedgecoe and Martin 2008). Nevertheless, we are keen for investigators
across disciplines to consider seriously what is at stake through interdisciplinary
endeavors, and the degree to which these have the potential to enrich their scholar-
ship, whilst also remaining attentive to the normative outcomes we are likely to
have a role in producing (Singh 2012).
Although it is not our intention in this paper to outline an agenda for social
science and epigenetics, we would like to discuss in just a little more detail the
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place of public and policy engagement in epigenetics. Given the engagement roles
that STS scholars regularly occupy when in intimate association with tech-
noscience, how this might progress is useful to consider. Social scientists involve-
ment in public engagement about contemporary developments in science is one
route through which they are able to contribute their professional expertise in the
public domain. Such engagement can generate critical space and dialogue, high-
lighting complexity, uncertainty and ambivalence (Kerr, Cunningham-Burley,
and Tutton 2007). Working with scientists to promote sociologically informed
public engagement can provide an alternative to a marketization of public engage-
ment, where dialogic events are commissioned to specialist organizations. While
successful and professional enterprises, they tend to operate with temporary afﬁlia-
tions to speciﬁc scientiﬁc developments or teams and by necessity with a shorter-
term view and narrowly deﬁned outcomes. Notwithstanding the on-going debates
about “public sociology” (Burawoy 2005; Calhoun 2005; Tittle 2004), we suggest
that we need to maintain social scientiﬁc perspectives and presence within public
and policy discussions, bringing normative energy to our activities without nar-
rowly specifying outcomes. In addition to the oft-rehearsed mantra to move
public engagement upstream, we propose too that attention should be paid to poten-
tial downstream effects, in terms of the trajectories of the translation of epigenetic
research into policy and practice (for example, through therapies and the practices
of health care they may enjoin).
In sum, then, we cannot “predict where a focus on epigenetics in a postgenomic
world will lead our life scientists” (Rapp 2011, 678) – nor can we assert with con-
ﬁdence what kinds of wider shifts in medicine and society we will see as a con-
sequence. Social scientiﬁc engagements with this area of research, however,
have the potential to shape the new territory being explored; hence, the ways
through which collaboration and critique might and should play out require reﬂec-
tion. Lessons from social scientists’ engagement in other areas of biomedicine –
e.g. genetics and genomics, regenerative medicine, synthetic biology and neuro-
science – suggest that our roles will be freighted with different expectations
from our peers, life scientists, governments and industry, and the “insider/outsider”
position familiar to many empirical researchers will prove challenging as well as
creative.
Discussion
In light of the promissory aspect of epigenetics, it is perhaps not surprising that the
attention of humanities scholars and social scientists has begun to be attracted by
developments in this ﬁeld.11 Some commentators have found cause for optimism
in the multimodality of epigeneticists’ developmental models (e.g. Nicolosi and
Ruivenkamp 2012; Papadopoulos 2011). These certainly appear to suggest the
need for revisiting social scientiﬁc theories of embodiment, habitualization and
the reproduction of social inequality. Yet, even apparently complex developmental
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imaginaries may nevertheless contain implicit assumptions about the nature of
social life, which may warrant questioning. The hopes and fears that might
adhere to epigenetic discourse imply different roles, and responsibilities, for STS
scholars (and those of related disciplines, including health geography, environ-
mental sociology, queer studies, and so on). Epigenetics might usefully be con-
sidered both as a “case” through which to explore sociological themes – such as
biomedicalization (Clarke et al. 2010), biopolitics (Lemke 2011), and expertise
(Collins and Evans 2007) – and as an area of import in its own right (or, in Wil-
liams’ (2011) terms, as both a “prism” and a “problem”). In the latter instance,
social scientists could actively seek to inﬂuence the development of epigenetics
by critically engaging with scientists, as well as wider publics (Cunningham-
Burley 2006) and the actors and institutions constituting the sociotechnical
spaces inside which investigations operate.
In spite of the novelty ascribed to epigenetics, the ﬁeld also builds on established
genome sequencing technologies and infrastructures. We might, then, reﬂect on
Landecker’s (2010) recent warning to scholars of biomedicine and society:
A problem that arises with accepting high-proﬁle entities or practices as given cat-
egories of analysis or boundaries of research projects is that one can easily mistake
the thing as the origin of the phenomena which follow it or accompany it in the dis-
courses under study. (220)
Fields, practices or conceptualizations that might appear uniquely novel or transfor-
mative may instead turn out to be “just one of many outcomes of a systematic
change” in research technique (Landecker 2010, 221). Landecker suggests there-
fore that analysts might more fruitfully focus their attention to the methodological
and infrastructural context within which objects of (temporary) prominence
emerge. Her point is well taken; however, we also regard the construction of
novelty itself as a pertinent, and potentially conceptually and empirical rich,
point of departure for social scientiﬁc analysis (Pickersgill 2013). If epigenetics
is taken by some to be “one of the most promising and expanding ﬁelds in the
current biomedical research landscape” (Rodrı´guez-Paredes and Esteller 2011,
330), then the logics underlying this are worth mapping; so, too, are the contexts
and instances where such celebratory discourse is accepted, rejected, or even
ignored (Pickersgill 2013; Stadler 2012).
Finally, we suggest that it will be useful to reﬂexively consider how the societal
dimensions of epigenetics are themselves being performed through social scientiﬁc
analysis. Extending our reﬂections on how we turn “epigenetics” into a “case” for
STS research, we need to ask: what ontological work is necessary when we place
boundaries around forms of epigenetic praxis in order to render it amenable for our
inspection, and to what end? Further, how appropriate is it to translate concepts and
ideas developed in, for instance, the social studies of genetics and neuroscience for
the analysis of epigenetics (see Rappert 2007)? The translation of analytic strategies
and explanatory frameworks between different case studies is not an “innocent”
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activity; it enacts the world in particular ways (cf. Law 2004). Our conceptual and
methodological agendas shape the nature of our research and its implications, and
these are themselves contoured profoundly by wider disciplinary debate (and,
indeed, fashion): as Wyatt and Balmer (2007) note, within STS “there can be a
moral pressure to relate ‘micro’ level work to the ‘bigger picture,’ and, on the
other hand, there can be a zealousness associated with doing microlevel, case
study work” (622). These and other approaches will shape social scientiﬁc engage-
ments with epigenetics in important ways. In light of the emergence of social and
biomedical research around “epigenetics”, we might regard this as a timely case
through which to consider the nature of caseness itself. In this way, STS analyses
of epigenetics may more easily resist complaints of being “just another case study”
(Beaulieu, Schanhorst, and Wouters 2007).
Conclusion
Research in epigenetics is gaining widespread attention in a range of spheres,
including the social sciences. The production of epigenetic knowledge is related
to new and established technologies, tools and methodologies, rapidly growing
public and private investment (such as (inter)national research programs to
develop epistemic infrastructure), and increasing numbers of publications. Signiﬁ-
cant questions remain to be addressed in light of this: how is epigenetics being ima-
gined and developed; what forms of knowledge, practices and applications are
considered salient; and how are these being compared and related to genomics?
Further, what notions of society and social groups are implicit within research
and materialized through it; how will political and clinical gazes be (re)orientated
through recourse to epigenetic imaginaries; and what kinds of social and ethical
responses will be appropriate in light of any ensuing shifts in policy and practice?
More reﬂexively, what role can and should social scientiﬁc commentators play
through attending to these diverse issues: “advocates, intermediaries, translators,
connoisseurs, critics, activists” (Calvert and Martin 2009, 201) – or perhaps
better yet, all of these? The answers to these questions have implications for the
kinds of networks that can be built to propel social scientiﬁc and biomedical inno-
vation, and the policy and clinical dimensions and consequence of it. As such the
issues outlined here merit further reﬂection and consideration.
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Notes
1. Today, prominent researchers such as Bird (2007) and McGowan and Szyf (2010; see also
Bollati and Baccarelli, 2010; Richards, 2006) argue that it is not scientiﬁcally useful to
restrict the deﬁnition of epigenetics to include only the study of markers and processes that
are heritable.
2. This talk is currently somewhat muted, and primarily restricted to STS-fora, though certainly
publications and conference presentations bringing in discussions of epigenetics are increasing.
3. Satterlee (a senior scientist at the US NIH), Schu¨beler, and Ng (2010) have summarized some of
the infrastructural projects currently fostering research into epigenetics; these include: The
Australian Epigenetics Alliance, the European Epigenome Network of Excellence, the NIH
Roadmap Epigenomics Program, and the International Human Epigenome Consortium
4. By “reﬂexively”, we mean here not simply motivated by common interest in a ﬁeld but rather in
full awareness of epistemic cultures and conﬂicts, competitors and funding streams.
5. Notably, though, the expectations and emphases apparent within more popular discourse on
epigenetics – which focus on the heritability and environmentally determined aspects of
epigenetic modiﬁcation – are more contested within the scientiﬁc literature. This should come as
no surprise to STS scholars, but it does underscore the importance of continued sociological
examinations of the material and rhetorical vehicles by which emergent knowledge travels
between discursive arenas.
6. See, for instance, Feil and Fragga (2012), Houston et al. (2013), Jirtle and Skinner (2007), and
Satterlee, Schu¨beler, and Ng (2010).
7. Indeed, even the prominent experimental work cited above has been subject to critique by other
scientists.
8. However, the existing STS literature on the dynamics of expectations does acknowledge that the
promises made by funders and other institutions do not necessarily match the more modest
hopes of individual scientists (Pickersgill, 2011).
9. Such framings resonate with discourses associated with the so-called Barker or “thrifty
phenotype” hypothesis (Barker, 1990; Hales and Barker, 1992).
10. This is a relevant issue for other interdisciplinary ventures, some of which have implications for
sociological research itself; see, for instance, Halford, Pope, and Weal (2013).
11. We use the somewhat teleological phrase “begun to be” advisedly but, we think, fairly, given the
great degree to which STS and bioethics has been responsive to highly-visible developments in
science and medicine.
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